Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation

Yasmin A. Lyons, Michael Frumovitz, Pamela T. Soliman

Research output: Contribution to journalArticlepeer-review

40 Scopus citations
Original languageEnglish (US)
Pages (from-to)28-29
Number of pages2
JournalGynecologic Oncology Reports
Volume10
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Keywords

  • KRAS mutation
  • MEK inhibitor
  • Small cell neuroendocrine carcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this